A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

Completed · Phase 2

Conditions studied: Peritoneal Cancer, Ovarian Cancer, Neoplasms, Ovarian, Fallopian Tube Cancer

In brief

This study was designed to find out how effective and safe GW786034, is in the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer that has not responded to standard treatment.

Key facts

Study ID

NCT00281632

Run by

GlaxoSmithKline

People needed

35

Starts

2006-03-01

Expected to finish

2010-10-01

Last updated by the study team

2018-09-17

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed diagnosis of epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
• Has received one prior platinum-based chemotherapy regimen(cisplatin,carboplatin, or oxaliplatin).
• Has psychological, familial, sociological or geographical condition that does not permit compliance with the protocol.
• Is on a specifically prohibited medication or requires these medications during treatment with GW786034.

You may not qualify if…

• Has had any surgery, chemotherapy, hormonal therapy, biologic, immunotherapy, or radiotherapy with in the last 28 days and has not recovered from such prior therapy.
• Poorly controlled hypertension(systolic 140mmHg or higher or Diastolic 90mmHg or higher).
• Currently taking warfarin.
• Low molecular weight heparin and low-dose warfarin(1mg per day)is permitted.

Where it is running

• GSK Investigational Site — Atlanta, Georgia, United States
• GSK Investigational Site — Austin, Texas, United States
• GSK Investigational Site — Bedford, Texas, United States
• GSK Investigational Site — Dallas, Texas, United States
• GSK Investigational Site — Fort Worth, Texas, United States
• GSK Investigational Site — Randwick, New South Wales, Australia
• GSK Investigational Site — Herston, Queensland, Australia
• GSK Investigational Site — Melbourne, Australia
• GSK Investigational Site — Singapore, Singapore
• GSK Investigational Site — Singapore, Singapore

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.